Op deze pagina vindt u publicaties van het RECOVAC consortium en de laatst gegeven webinar in samenwerking met de Nierpatiënten Vereniging Nederland (NVN). Via de rode link in de titel komt u terecht bij artikel.
Imhof et al. – 2023 november – Viruses – The Time-Dependent Association of Torque Teno Virus Load with the Level of SARS-CoV-2 S1 IgG Antibodies Following COVID-19 Vaccination in Kidney Transplant Recipients
Frölke et al. – 2023 augustus – eClinicalMedicine – Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study
Fröberg et al. – 2023 september – Journal Infectious Diseases – Primary exposure to SARS-CoV-2 via infection or vaccination determines mucosal antibody-dependent ACE2 binding inhibition
Messchendorp et al. – 2023 juni – Nephrology Dialysis Transplantation – Vaccinated kidney transplant recipients are yet not sufficiently protected against COVID-19.
Malahe et al. – 2023 juni – American Journal of Transplantation – The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
Den Hartog et al. – 2023 mei – NPJ vaccines – Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.
Meziyerh et al. – 2023 februari – Clinical Pharmacology & Therapeutics – Mycophenolic Acid Exposure Determines Antibody Formation Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study
Bouwmans et al. – 2022 november – Clinical Kidney Journal – Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy
Kho et al. – 2022 oktober – Lancet Infectious Diseases– Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial
Imhof et al. – 2022 oktober – Transplant Direct – SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
Frölke et al. – 2022 oktober – Transplant Direct – Predictors of Nonseroconversion to SARS-CoV-2 Vaccinatination in Kidney Transplant Recipients
Sanders et al. – 2022 juli – Clinical Infectious Diseases – Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
Al Fatly et al. – 2022 juni – Kidney International Reports – COVID-19 Vaccination Response in Kidney Transplant Recipients With and Without Mycophenolate Mofetil: Follow-up of a Randomized Controlled Trial
Sanders et al. – 2022 april – Transplantation – The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
De Vries et al. – 2021 december – Journal of Clinical Investigation – Difference in sensitivity between SARS-CoV-2 specific T cell assays in patients with underlying conditions
Bouwmans et al. – 2022 februari – BMC Nephrology – Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study
Kho et al. – 2021 augustus – Nephrology Dialysis Transplantation – The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant
Webinars
Webinar najaar 2023: Hoe ziek kan ik nog worden van COVID-19? Heeft vaccinatie zin en welk vaccin krijg ik dan? Wat voor maatregelen kan ik verder nog nemen? Deze, en andere vragen worden beantwoord in dit achtste webinar van de NVN over COVID-19.
